skip to main content

Focused on Cancer Centered on You

Patients and Families:  Our dedicated cancer teams provide personalized treatment plans for our patients. 

Find a Doctor Learn About Cancer Clinical Trials

The Key to Research is Collaboration

Through our focus on team science and research excellence, we aim to be a national leader in cancer prevention, early diagnosis, optimal treatment and survivorship care.

Read About Our Research Programs

Committed to Training NextGen Cancer Doctors and Researchers

In addition to fellowships and doctoral programs, we also offer training opportunities including access to funding and seminars.

See the Opportunities

News

  • Storytelling is central to honoring diversity in Rogel OCTSU

    Everyone has a story. And those stories help show the different influences on each person’s life, helping to build empathy, challenge stereotypes and create a more inclusive environment. That’s the basis of a new DEI initiative the Rogel Oncology Clinical Trials Support Unit, or OCTSU, has started. DEI Storytelling gives a platform for team members to share their personal journey, anecdotes or reflections, with an emphasis on topics that may not be widely understood by all staff.
    Read More >
  • Rogel Cancer Center research to be presented at ASH annual meeting 2023

    Rogel Cancer Center faculty and trainees will lead more than three dozen presentations, posters and moderated sessions at the American Society of Hematology 2023 annual meeting. This year’s meeting will be held in-person and virtually in San Diego, California. Find a list of U-M presenters and other resources for attendees.
    Read More >
  • Rogel researcher gets $1.1M specialized grant to understand the biology of low-risk prostate cancer

    For men with a type of low-risk early prostate cancer, surveillance can be an option over immediate treatment. To help providers and patients make more informed decisions about safely choosing surveillance, Rogel Cancer Center researcher Simpa Salami, M.D., M.P.H., received a $1.14 million grant from the National Cancer Institute to answer lingering questions about the biology of these early prostate cancers.
    Read More >

Visiting Rogel Cancer Center

As part of Michigan Medicine, we offer cancer care at a number of locations throughout Michigan.

See Our Locations

We are a comprehensive cancer center

Designated by the National Cancer Institute, we follow a team-based approach to cancer not only in patient care but also in research and education.

Learn More About What Sets Us Apart

Thrive: Living with Cancer

QUESTIONS ABOUT CANCER?

Cancer AnswerLine™ is a free community service for patients and families who have questions about cancer.

1-800-865-1125

Multimedia + Social Media

Image of the YouTube player and the intro to Lung Cancer Screening

Lung Cancer Screening

U-M lung specialists Ella A Kazerooni, M.D., M.S., and Douglas Arenberg, M.D., discuss lung cancer screening for those at high risk.

Image of the podcast player for the cancer drug shortages podcast podcast

Cancer Drug Shortages

In this episode, head and neck surgical oncologist Andrew G. Shuman, M.D., FACS, HEC-C, discuses the current cancer drug shortages and how they’re impacting patient care nationwide.

Image of finger touching a social media button

Talk to Us

For up-to-the-minute news and information, visit us on our social media channels!